Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

480 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
Numata K, Fukuda H, Morimoto M, Kondo M, Nozaki A, Oshima T, Okada M, Takebayashi S, Maeda S, Tanaka K. Numata K, et al. Among authors: takebayashi s. Eur J Radiol. 2012 Oct;81(10):2746-53. doi: 10.1016/j.ejrad.2011.11.052. Epub 2011 Dec 23. Eur J Radiol. 2012. PMID: 22197088 Clinical Trial.
Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K, Numata K, Morimoto M, Kondo M, Nozaki A, Moriya S, Ishii T, Oshima T, Fukuda H, Okada M, Takebayashi S, Maeda S, Tanaka K. Takizawa K, et al. Among authors: takebayashi s. Eur J Radiol. 2013 Sep;82(9):1471-80. doi: 10.1016/j.ejrad.2013.04.045. Epub 2013 Jun 13. Eur J Radiol. 2013. PMID: 23769188 Clinical Trial.
Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
Numata K, Fukuda H, Nihonmatsu H, Kondo M, Nozaki A, Chuma M, Morimoto M, Oshima T, Okada M, Murakami T, Takebayashi S, Maeda S, Inayama Y, Nakano M, Tanaka K. Numata K, et al. Among authors: takebayashi s. Abdom Imaging. 2015 Oct;40(7):2372-83. doi: 10.1007/s00261-015-0489-6. Abdom Imaging. 2015. PMID: 26099473
A new device for fiducial registration of image-guided navigation system for liver RFA.
Doba N, Fukuda H, Numata K, Hao Y, Hara K, Nozaki A, Kondo M, Chuma M, Tanaka K, Takebayashi S, Koizumi N, Kobayashi A, Tokuda J, Maeda S. Doba N, et al. Among authors: takebayashi s. Int J Comput Assist Radiol Surg. 2018 Jan;13(1):115-124. doi: 10.1007/s11548-017-1647-9. Epub 2017 Jul 17. Int J Comput Assist Radiol Surg. 2018. PMID: 28718001
Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US.
Sugimori K, Numata K, Okada M, Nihonmatsu H, Takebayashi S, Maeda S, Nakano M, Tanaka K. Sugimori K, et al. Among authors: takebayashi s. J Med Ultrason (2001). 2017 Jan;44(1):89-100. doi: 10.1007/s10396-016-0750-9. Epub 2016 Oct 22. J Med Ultrason (2001). 2017. PMID: 27771842
480 results